Stevens-Johnson syndrome after treatment with STI571: a case report

scientific article published in June 2002

Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 159 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 159 Warning: foreach() argument must be of type array|object, null given in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 161
Stevens-Johnson syndrome after treatment with STI571: a case report is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1365-2141.2002.03499.X
P698PubMed publication ID12028031
P5875ResearchGate publication ID11344383

P2093author name stringJin-Hwang Liu
Liang-Tsai Hsiao
Po-Min Chen
Tzeon-Jye Chiou
Wei-Shu Wang
Chueh-Chuan Yen
Jen-Tsun Lin
Frank S Fan
Hung-Ming Chung
P2860cites workEfficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemiaQ29547900
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosomeQ33336718
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumorQ33941495
Severe adverse cutaneous reactions to drugsQ34314152
Cutaneous reactions to STI571.Q43723840
A NEW ERUPTIVE FEVER ASSOCIATED WITH STOMATITIS AND OPHTHALMIAQ56066353
Induction of hyperacute graft-vs-host disease after donor leukocyte infusionsQ74623404
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectimatinibQ177094
Stevens–Johnson syndromeQ1053948
P304page(s)620-622
P577publication date2002-06-01
P1433published inBritish Journal of HaematologyQ4970200
P1476titleStevens-Johnson syndrome after treatment with STI571: a case report
P478volume117

Reverse relations

cites work (P2860)
Q38729029A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor
Q44339633A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec).
Q37930709Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib.
Q45152647Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors
Q38103997Adverse skin effects of imatinib, a tyrosine kinase inhibitor
Q54987295Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.
Q37433981Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor
Q28070095Cutaneous complications of molecular targeted therapy used in oncology
Q44964913Cutaneous side effects with imatinib (Glivec)
Q80178563Desensitization to imatinib in patients with leukemia
Q45227567Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib
Q36753920Erythema multiforme and related disorders
Q46972774Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib
Q42087836Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib
Q33662660Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor.
Q37183434Imatinib mesylate for the treatment of chronic myeloid leukemia
Q38101103Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience.
Q36705526Imatinib-induced Stevens-Johnsons syndrome
Q45023013Lichenoid cutaneous reaction to imatinib
Q41869634Life-threatening dermatologic adverse events in oncology
Q44665259Overcoming recurrent cutaneous reactions from imatinib using once-weekly dosing
Q35748794Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
Q50897717Pityriasis rubra pilaris-like reaction induced by imatinib
Q34443523Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
Q34666762Serious skin reaction associated with imatinib in a patient with chronic myeloid leukemia
Q55115766Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.
Q45610652Stevens-Johnson Syndrome Induced by Sorafenib for Metastatic Renal Cell Carcinoma
Q36822880Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).
Q40466877[Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy]

Search more.